Vaccine Associated with Reduced Dementia Risk

A recent study suggests that receiving the Shingrix shingles vaccine may be associated with a 24% reduction in dementia risk among older adults, based on analysis of health records of over 500,000 individuals. Experts emphasize that the findings show correlation, not causation, and the vaccine's primary purpose remains preventing shingles and its complications. Researchers propose that preventing shingles and related vascular issues could contribute to the observed link to cognitive health.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article